Price
$1.34
Decreased by -3.80%
Dollar volume (20D)
41.62 K
ADR%
10.53
Shares float
27.96 B
Shares short
76.99 K [0.00%]
Shares outstanding
28.88 M
Market cap
40.72 M
Beta
0.29
Price/earnings
0.00
20D range
1.03 1.58
50D range
0.85 1.73
200D range
0.85 4.40

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases.

Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities.

The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA.

The company is headquartered in Boston, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Dec 6, 24 -0.24
Decreased by N/A%
-
Sep 30, 24 -0.80
Decreased by -903.13%
-
May 15, 24 -0.83
Decreased by -934.38%
-
Oct 12, 23 0.00
Increased by +100.00%
-0.60
Increased by +100.00%
Sep 29, 23 0.00
Increased by +100.00%
-1.20
Increased by +100.00%
May 1, 23 -0.08
Increased by +34.21%
-0.07
Decreased by -14.29%
Mar 30, 23 -0.08
Decreased by -156.41%
-0.07
Decreased by -14.29%
Dec 30, 22 -0.04
Increased by +73.65%
-0.04
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 N/A
Decreased by N/A%
-3.77 M
Increased by +32.23%
- -
Dec 31, 24 0.00
Decreased by N/A%
-3.77 M
Decreased by -7.63%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-2.90 M
Increased by +17.40%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-7.56 M
Decreased by -151.97%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-5.57 M
Decreased by -656.04%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-3.50 M
Decreased by -1.71%
Decreased by N/A%
-
Sep 30, 23 0.00
Decreased by N/A%
-3.50 M
Decreased by -1.71%
Decreased by N/A%
-
Jun 30, 23 0.00
Decreased by N/A%
-3.00 M
Increased by +12.95%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY